Feedback / Questions
AP303 - Alebund
https://www.prnewswire.com/news-releases/alebunds-innovative-investigational-drug-ap303-receives-fda-orphan-drug-designation-odd-for-the-treatment-of-autosomal-dominant-polycystic-kidney-disease-adpkd-302101896.html
Mar 29, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next